お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は非ステロイド系抗炎症剤市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは非ステロイド系抗炎症剤の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の非ステロイド系抗炎症剤市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは非ステロイド系抗炎症剤のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に非ステロイド系抗炎症剤市場を分類しています。本研究に含まれる主な企業は：Roche (Genentech)、Amgen、B-MS、Merck、Pfizer、Novartis、Eli Lilly and Company、Johnson & Johnson、GSK、Sanofi、Boehringer Ingelheim、Zhejiang Jiuzhou Pharmaceutical

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Aspirin
    Ibuprofen
    Naproxen
    Celecoxib
    Others

用途別の市場セグメント：
    Drug Store
    Hospital Pharmacies
    Online

本レポートの詳細内容
世界の非ステロイド系抗炎症剤市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、非ステロイド系抗炎症剤タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の非ステロイド系抗炎症剤収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の非ステロイド系抗炎症剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、非ステロイド系抗炎症剤市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

非ステロイド系抗炎症剤のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：非ステロイド系抗炎症剤のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：非ステロイド系抗炎症剤の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章非ステロイド系抗炎症剤企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：非ステロイド系抗炎症剤の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：非ステロイド系抗炎症剤の主要企業の概要を提供し、製品の説明と仕様、非ステロイド系抗炎症剤の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
Market Analysis and Insights: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Roche (Genentech)
    Amgen
    B-MS
    Merck
    Pfizer
    Novartis
    Eli Lilly and Company
    Johnson & Johnson
    GSK
    Sanofi
    Boehringer Ingelheim
    Zhejiang Jiuzhou Pharmaceutical

Segment by Type
    Aspirin
    Ibuprofen
    Naproxen
    Celecoxib
    Others

Segment by Application
    Drug Store
    Hospital Pharmacies
    Online

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Aspirin
    Table 3. Key Players of Ibuprofen
    Table 4. Key Players of Naproxen
    Table 5. Key Players of Celecoxib
    Table 6. Key Players of Others
    Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2024)
    Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2025-2030)
    Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
    Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
    Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
    Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
    Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2019-2024)
    Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)
    Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Headquarters and Area Served
    Table 23. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application
    Table 24. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2019-2024)
    Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2025-2030)
    Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)
    Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2025-2030)
    Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Roche (Genentech) Company Details
    Table 67. Roche (Genentech) Business Overview
    Table 68. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 69. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 70. Roche (Genentech) Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 74. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. B-MS Company Details
    Table 77. B-MS Business Overview
    Table 78. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 79. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 80. B-MS Recent Developments
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 84. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 85. Merck Recent Developments
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 89. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 90. Pfizer Recent Developments
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 94. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 95. Novartis Recent Developments
    Table 96. Eli Lilly and Company Company Details
    Table 97. Eli Lilly and Company Business Overview
    Table 98. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 99. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 100. Eli Lilly and Company Recent Developments
    Table 101. Johnson & Johnson Company Details
    Table 102. Johnson & Johnson Business Overview
    Table 103. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 104. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 105. Johnson & Johnson Recent Developments
    Table 106. GSK Company Details
    Table 107. GSK Business Overview
    Table 108. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 109. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 110. GSK Recent Developments
    Table 111. Sanofi Company Details
    Table 112. Sanofi Business Overview
    Table 113. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 114. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 115. Sanofi Recent Developments
    Table 116. Boehringer Ingelheim Company Details
    Table 117. Boehringer Ingelheim Business Overview
    Table 118. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 119. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 120. Boehringer Ingelheim Recent Developments
    Table 121. Zhejiang Jiuzhou Pharmaceutical Company Details
    Table 122. Zhejiang Jiuzhou Pharmaceutical Business Overview
    Table 123. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
    Table 124. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)
    Table 125. Zhejiang Jiuzhou Pharmaceutical Recent Developments
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2023 VS 2030
    Figure 3. Aspirin Features
    Figure 4. Ibuprofen Features
    Figure 5. Naproxen Features
    Figure 6. Celecoxib Features
    Figure 7. Others Features
    Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2023 VS 2030
    Figure 10. Drug Store Case Studies
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Online Case Studies
    Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
    Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2023 VS 2030
    Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2023
    Figure 18. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023
    Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)
    Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)
    Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)
    Figure 24. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)
    Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)
    Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)
    Figure 30. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)
    Figure 38. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)
    Figure 39. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)
    Figure 41. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)
    Figure 42. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2030)
    Figure 43. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)
    Figure 53. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 60. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 61. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 62. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 63. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 64. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 65. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 66. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 67. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 68. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 69. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 70. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed